Clotrimazole (mucous membrane)

Clotrimazole (mucous membrane)
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Clotrimazole (mucous membrane) is an Azole Antifungal that is FDA approved for the treatment of tinea pedis, tinea cruris, tinea corporis. Common adverse reactions include Nausea, Vomiting.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Anti-Fungal

• Dosing information

• Clean the affected area and dry thoroughly. Apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor. Supervise children in the use of this product. For athlete's foot: Pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily. For athlete's foot and ringworm, use daily for 4 weeks; for jock itch, use daily for 2 weeks. If condition persists longer, consult a doctor. This product is not effective on the scalp or nails.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Clotrimazole in adult patients.

Non–Guideline-Supported Use

Candidal vulvovaginitis

• Dosing information

• 0.5 grams administered once weekly for 2 weeks

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding Clotrimazole (mucous membrane) FDA-Labeled Indications and Dosage (Pediatric) in the drug label.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Clotrimazole in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Clotrimazole in pediatric patients.

Contraindications

Hypersensitivity to clotrimazole.

Warnings

For exteranl use only.

If swallowed, get medical help or contact a Poison Control Center right away.

Do not use on children under 2 years of age unless directed by a doctor.

Avoid contact with the eyes.

If irritation occurs or if there is no improvement within 2 weeks, discontinue use and consult a doctor.

Keep out of reach of children

Adverse Reactions

Clinical Trials Experience

Common gastrointestinal: nausea, vomiting.

Postmarketing Experience

FDA Package Insert for Allopurinol contains no information regarding Postmarketing experience.

Drug Interactions

There is limited information regarding Clotrimazole (mucous membrane) Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Clotrimazole (mucous membrane) in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Clotrimazole (mucous membrane) in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Clotrimazole (mucous membrane) during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Clotrimazole (mucous membrane) in women who are nursing.

Pediatric Use

There is no FDA guidance on the use of Clotrimazole (mucous membrane) in pediatric settings.

Geriatic Use

There is no FDA guidance on the use of Clotrimazole (mucous membrane) in geriatric settings.

Gender

There is no FDA guidance on the use of Clotrimazole (mucous membrane) with respect to specific gender populations.

Race

There is no FDA guidance on the use of Clotrimazole (mucous membrane) with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Clotrimazole (mucous membrane) in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Clotrimazole (mucous membrane) in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Clotrimazole (mucous membrane) in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Clotrimazole (mucous membrane) in patients who are immunocompromised.

Administration and Monitoring

Administration

For exteranl use only.

Monitoring

FDA Package Insert for Clotrimazole contains no information regarding Drug Monitoring.

IV Compatibility

There is limited information about the IV Compatibility.

Overdosage

There is limited information regarding Clotrimazole (mucous membrane) overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

Pharmacology

There is limited information regarding Clotrimazole (mucous membrane) Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Clotrimazole (mucous membrane) Mechanism of Action in the drug label.

Structure

There is limited information regarding Clotrimazole (mucous membrane) Structure in the drug label.

Pharmacodynamics

There is limited information regarding Clotrimazole (mucous membrane) Pharmacodynamics in the drug label.

Pharmacokinetics

There is limited information regarding Clotrimazole (mucous membrane) Pharmacokinetics in the drug label.

Nonclinical Toxicology

There is limited information regarding Clotrimazole (mucous membrane) Nonclinical Toxicology in the drug label.

Clinical Studies

There is limited information regarding Clotrimazole (mucous membrane) Clinical Studies in the drug label.

How Supplied

There is limited information regarding Clotrimazole (mucous membrane) How Supplied in the drug label.

Storage

There is limited information regarding Clotrimazole (mucous membrane) Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Clotrimazole (mucous membrane) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Clotrimazole (mucous membrane) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Clotrimazole (mucous membrane) Patient Counseling Information in the drug label.

Precautions with Alcohol

Alcohol-Clotrimazole interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

3 Day Vaginal Cream Clotrim Antifungal Cruex Prescription Strength Gyne-Lotrimin Gyne-Lotrimin 3 Lotrimin Lotrimin AF Mycelex

Look-Alike Drug Names

There is limited information regarding Clotrimazole (mucous membrane) Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

{{#subobject:

 |Label Page=Clotrimazole (mucous membrane)
 |Label Name=Clotrimazole_label_01.jpg

}}

{{#subobject:

 |Label Page=Clotrimazole (mucous membrane)
 |Label Name=Clotrimazole_panel_01.png

}}